Skip to main content
. 2012 Nov 20;107(12):1932–1937. doi: 10.1038/bjc.2012.509

Table 3. Toxicity of the FOLFOXIRI/erbitux combination in all patients and all cycles.

  Grade 1 Grade 2 Grade 3 Grade 4
  No. of patients % No. of patients % No. of patients % No. of patients %
Haematologic toxicity
 Neutropenia 3 10.0 5 16.7 6 20.0 1 3.3
 Anaemia 13 43.3 10 33.3 1 3.3
 Thrombocytopenia 7 23.3 2 6.7
 Febrile neutropenia 1 3.3 1 3.3
                 
Non-haematologic toxicity
 Nausea 6 20.0 3 10.0 1 3.3
 Vomiting 3 10.0 3 10.0 4 13.3
 Diarrhoea 6 20.0 5 16.7 13 43.3 3 10.0
 Stomatitis 5 16.7 5 16.7 3 10.0
 Constipation 3 10.0
 Neurotoxicity 7 23.3 2 6.7
 Allergy 5 16.7 4 13.3
 Asthenia 8 26.7 6 20.0
 Hand/Foot 2 6.7 3 10.0 1 3.3
 Rush 6 20.0 4 13.3 1 3.3